Neurana Pharmaceuticals is a privately-held clinical-stage San Diego-based specialty pharmaceutical company developing a novel treatment for acute muscle spasms.  The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders.

Biotechnology

Neurana Pharmaceuticals

Neurana Pharmaceuticals' headquarters in San Diego, CA, United States

Johnna Simões

Kathy Scott

Catherine Brisson

David Kabakoff

Brian Dorsey

Georgia Erbez

David Hale

Ron Hunt

Alex Zisson

The Directors Team at Neurana Pharmaceuticals is responsible for overseeing the strategic direction and overall management of the company's clinical-stage development efforts. This team ensures that all departments align with the company's goals of advancing novel treatments for CNS diseases and disorders, particularly focusing on acute muscle spasms. They play a crucial role in decision-making, compliance, and coordinating cross-functional initiatives to drive the company's success.

Directors Team

The Leadership Team at Neurana Pharmaceuticals is responsible for setting the strategic direction of the company, overseeing the development and regulatory processes of innovative treatments for acute muscle spasms, and ensuring financial sustainability and compliance. This team, comprising top executives including the President & CEO, CFO, and CMO, collaborates to drive clinical advancements and navigate the complexities of the pharmaceutical landscape, ultimately aiming to improve patient outcomes in central nervous system disorders.

Neurana Pharmaceuticals

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Neurana Pharmaceuticals

Org chart

Board & advisors

Teams

Directors Team

Leadership Team

Offices

Related companies